Detalles de la búsqueda
1.
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis.
Cancer Immunol Immunother
; 70(7): 1929-1937, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33409737
2.
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 15(3)2023 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765812
3.
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan.
J Gastrointest Oncol
; 14(2): 849-862, 2023 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37201085
4.
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma.
Pharmaceutics
; 14(11)2022 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36365082
5.
Validation of the GOLD 2017 and new 16 subgroups (1A-4D) classifications in predicting exacerbation and mortality in COPD patients.
Int J Chron Obstruct Pulmon Dis
; 13: 3425-3433, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30425472
Resultados
1 -
5
de 5
1
Próxima >
>>